AcMNPV |
Autographa californica Multiple Nucleopolyhedrovirus |
BEVS |
baculovirus-based protein expression system |
ODV |
occlusion-derived virus |
OB |
occlusion bodies |
BV |
budded virus |
HA |
hemagglutinin |
ZIKV |
Zika virus |
VSV |
Vesicular stomatitis virus |
VSV-G |
Vesicular stomatitis virus glycoprotein |
TBV |
transmission-blocking vaccines |
VLP |
virus-like particles |
MOI |
multiplicity of infection |
HIV |
Human immunodeficiency virus |
SP |
signal peptide |
TM |
transmembrane |
CTD |
cytoplasmic terminal domain |
MHC |
major histocompatibility complex |
OVA |
ovalbumin |
PEI |
polyethylenimine |
PEG |
polyethylene glycol |
RIPK1 |
receptor interaction protein kinase 1 |
AAV |
adeno-associated virus |
FDA |
U.S. Food and Drug Administration |
CMV |
cytomegalovirus |
SV40 |
simian virus 40 |
CAG |
chicken beta-actin |
HBV |
Hepatitis B virus |
GOI |
gene of interest |
lncRNA |
long non-coding RNA |
shRNA |
short hairpin RNA |
gRNA |
guide RNA |
ncRNA |
Non-coding RNA |
RNAi |
interference RNA |
CRISPR |
clustered regularly interspaced short palindromic repeats |
EF1α |
elongation factor-1 alpha |
DAF |
decay accelerating factor |
EBV |
Epstein-Barr virus |